Johnson & Johnson COVID-19 vaccine to be made in Baltimore – WBAL TV Baltimore

TO GO. EMERGENT BIOSOLUTIONS HAS ABOUT 1,000 EMPLOYEES AT TWO BALTIMORE LOCATIONS THAT WILL MAKE THE JOHNSON & JOHNSON CORONAVIRUS VACCINE. THAT IS WHEN THE FOOD AND DRUG ADMINISTRATION GIVES THEM OK FOR MASS PRODUCTION. >> OVER THE COMING MONTHS, WE EXPECT TO MANUFACTURE HUNDREDS OF MILLIONS OF DOSES TO KEEP DOSES FLOWING TO THE AMERICAN POPULATION. PHIL: AS PART OF THE CLINICAL TRIALS THE COMPANY HEADQUARTERED IN GAITHERSBURG IS ALREADY MAKING THE VACCINE TO BUILD UP A STOCKPILE AND TO FILL THE PIPELINE, SO TO SPEAK, TO GET THE PRODUCT MOVING ONCE ITS -- IT IS APPROVED. THATS EXPECTED TO HAPPEN SOON. ITS ATTRACTIVE TO THOSE ON THE FRONT LINES BECAUSE THE VACCINE IS GIVEN IN ONE DOSE AND STORAGE IS MUCH EASIER THAN THOSE >> THE PRODUCT CANDIDATES WE ARE WORKING ON ARE STABLE AT REFRIGERATED TEMPERATURES, TWO TO EIGHT DEGREES CENTIGRADE. THATS A TYPICAL KIND OF CLINIC REFRIGERATION TEMPERATURES, WHICH MAKES THEM MORE EASILY DISTRIBUTED ACROSS THE GLOBE. PHIL: AND IN THE GLOBAL FIGHT AGAINST THE CORONAVIRUS PANDEMIC BALTIMORE WILL TRULY HAVE A HAND IN THE MAJOR BATTLE OF GETTING PEOPLE VACCINATED. >> THERES A LOT OF DEMAND OUT THERE. IM IN THE VACCINE BUSINESS. I RUN THE MANUFACTURING OF THIS ORGANIZATION, BUT IVE GOT A FAMILY AND MY FAMILY ASKS ME EVERY DAY. I GET LOTS OF TEXT MESSAGES ABOUT HOW ARE THINGS GOING AND WHEN ITS GOING TO BE AVAILABLE. ITS JUST AN AMAZING OPPORTUNITY WE HAVE TO LEAVE AND INDELIBLE MARK, A POSITIVE MARK ON THE COURSE OF AMERICAN HISTORY. PHIL: EMERGENT BIOSOLUTIONS ALSO HAS A CONTRACT WITH ASTROZENICA TO MAKE YET ANOTHER CORONAVIRUS VACCINE. THEY ARE ALSO MAKING A TREATMENT FOR THE CORONAVIRUS RIGHT HERE IN BALTIMORE

Johnson & Johnson COVID-19 vaccine to be made in Baltimore

Updated: 5:27 PM EST Jan 28, 2021

The Johnson & Johnson one-shot coronavirus vaccine is expected to be a game-changer in fighting COVID-19 -- and it will be made in Baltimore.|| Coronavirus updates | Maryland's latest numbers | Get tested | Vaccine Info ||Workers at Emergent BioSolutions near Johns Hopkins Bayview Medical Center said they are ready to go as soon as the U.S. Food and Drug Administration gives approval.Gaithersburg-based Emergent BioSolutions has about 1,000 employees at two Baltimore locations that will make the Johnson & Johnson coronavirus vaccine."Over the coming months, we expect to manufacture hundreds of millions of doses to keep doses flowing to the American population," said Sean Kirk, executive vice president of manufacturing and technical operations for Emergent BioSolutions.Maryland online vaccination site locatorVaccine Data DashboardMaryland vaccination plan FAQsAs part of the clinical trials, the company is already making the vaccine to build up a stockpile and to fill the pipeline to get the product moving once its approved, which is expected soon.The Johnson & Johnson vaccine is attractive to those on the front lines because the vaccine is given in one dose and storage is much easier than those already on the market."The product candidates we are working on are stable at refrigerated temperatures -- 2 to 8 degrees centigrade. That's a typical kind of clinic refrigeration temperatures, which makes them more easily distributed across the globe," Kirk said.In the global fight against the coronavirus pandemic, Baltimore will have a hand in the major battle of getting people vaccinated."It's just an amazing opportunity we have to leave an indelible mark, a positive mark on the course of American history," Kirk said. "There's a lot of demand out there. I'm in the vaccine business. I run the manufacturing of this organization, but I've got a family, and my family asks me every day, I get lots of text messages about how are things going and when it's going to be available."Emergent BioSolutions also has a contract with AstraZeneca to make its coronavirus vaccine. The company is also making a treatment for the coronavirus in Baltimore.

The Johnson & Johnson one-shot coronavirus vaccine is expected to be a game-changer in fighting COVID-19 -- and it will be made in Baltimore.

|| Coronavirus updates | Maryland's latest numbers | Get tested | Vaccine Info ||

Workers at Emergent BioSolutions near Johns Hopkins Bayview Medical Center said they are ready to go as soon as the U.S. Food and Drug Administration gives approval.

Gaithersburg-based Emergent BioSolutions has about 1,000 employees at two Baltimore locations that will make the Johnson & Johnson coronavirus vaccine.

"Over the coming months, we expect to manufacture hundreds of millions of doses to keep doses flowing to the American population," said Sean Kirk, executive vice president of manufacturing and technical operations for Emergent BioSolutions.

As part of the clinical trials, the company is already making the vaccine to build up a stockpile and to fill the pipeline to get the product moving once its approved, which is expected soon.

The Johnson & Johnson vaccine is attractive to those on the front lines because the vaccine is given in one dose and storage is much easier than those already on the market.

"The product candidates we are working on are stable at refrigerated temperatures -- 2 to 8 degrees centigrade. That's a typical kind of clinic refrigeration temperatures, which makes them more easily distributed across the globe," Kirk said.

In the global fight against the coronavirus pandemic, Baltimore will have a hand in the major battle of getting people vaccinated.

"It's just an amazing opportunity we have to leave an indelible mark, a positive mark on the course of American history," Kirk said. "There's a lot of demand out there. I'm in the vaccine business. I run the manufacturing of this organization, but I've got a family, and my family asks me every day, I get lots of text messages about how are things going and when it's going to be available."

Emergent BioSolutions also has a contract with AstraZeneca to make its coronavirus vaccine. The company is also making a treatment for the coronavirus in Baltimore.

The rest is here:

Johnson & Johnson COVID-19 vaccine to be made in Baltimore - WBAL TV Baltimore